Management Team and Scientific Advisory Board extension

Gaudenz von Capeller has been appointed Chief Financial Officer.
Professor Douglas Hanahan, Director of the Swiss Institute for Experimental Cancer Research (ISREC), has been appointed as Chairman of the Scientific Advisory Board. See our Press Release.